期刊文献+

ESRS评分对预测非心源性脑梗死患者复发的评价 被引量:2

The Essen Stroke Risk Score predict recurrent risk in Non-Cardiogenic Ischemic Stroke patients
下载PDF
导出
摘要 目的评价Essen卒中风险评分量表(ESRS)评分对短暂性脑缺血发作(TIA)及非心源性脑梗死患者复合血管事件发生情况的预测价值。方法连续入组TIA及非心源性脑梗死患者816例,随访1年期复合血管事件发生率。应用受试者工作特征(ROC)曲线评估ESRS在总体人群、TIA、小卒中、大卒中患者中预测复合血管事件发生的效度。结果完成1年期随访757例,总体人群、TIA、小卒中和大卒中患者的1年期复合血管事件发生率分别是15.98%、16.54%、14.04%、16.97%。ESRS评分预测复合血管事件发生的曲线下面积(AUC)值分别为0.611、0.585、0.605、0.614。结论 ESRS评分预测大卒中患者复合血管事件发生率的效度最高,小卒中其次,TIA的效度不理想。 Objective To evaluate the predictive values of Essen Stroke Risk Score( ESRS) scale for recurrent combined vascular events in patients after onset of non-Cardiogenic ischemic stroke and transient ischemic attack( TIA).Methods A total of 816 admitted patients with non- Cardiogenic ischemic stroke and TIA were followed up for one year.We evaluated the predictive accuracy of ESRS of recurrent combined vascular events in TIA,minor stroke and major stroke with area under receiver operating characteristic( ROC). Results 757 cases were completed of the 1-year follow-up survey. 1-year period of combined vascular event rate of the whole patients,TIA,minor stroke and major stroke were 15. 98%,16. 54%,14. 04%,16. 97%. The AUC were 0. 611,0. 585,0. 605,0. 614. Conclusion ESRS is equally able to predict the risk of recurrent combined vascular events in non-Cardiogenic ischemic stroke and TIA,although the predictive accuracy of the ESRS is the highest in major stroke,second in minor stroke and lowest in TIA.
出处 《中风与神经疾病杂志》 CAS 北大核心 2015年第3期251-253,共3页 Journal of Apoplexy and Nervous Diseases
基金 上海市宝山区科委科技发展基金(12-E-31)
关键词 ESRS评分 脑梗死 复发 Essen Stroke Risk Score Ischemic stroke Recurrent Predict
  • 相关文献

参考文献12

  • 1Hankey GJ.Long-term outcome after ischaemic stroke/transient ischaemic attack[J].Cerebrovasc Dis,2003,16(S1):14-19.
  • 2TouzéE,Varenne O,Chatellier G,et al.Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke:a systematic review and meta-analysis[J].Stroke,2005,36(12):2748-2755.
  • 3A randomised,blinded,trial of clopidogrel versus aspirin in Patients at risk of ischaemic events(CAPRIE).CAPRIE Steering Committee[J].Lancet,1996,348(9038):1329-1339.
  • 4Diener HC,Ringleb PA,Savi P.Clo Pidogrel for the secondary Prevention of Stroke[J].Ex Pert OPin Pharmacother,2005,6(5):755-764.
  • 5Chandratheva A,Geraghty OC,Rothwell PM.Poor performance of current prognostic scores for early risk of recurrence after minor stroke[J].Stroke,2011,42:632-637.
  • 6饶明俐.《中国脑血管病防治指南》摘要(三)[J].中风与神经疾病杂志,2006,23(1):4-8. 被引量:282
  • 7Weimar C,Goertler M,Rother J,et al.Systemic risk score evaluation in ischemic stroke Patients(SCALA):a Pros Pective cross sectional study in 85 German stroke units[J].J Neurol,2007,254(11):1562-1568.
  • 8Weimar C,Goertler M,Rother J.Predictive value of the Essen Stroke Risk Score and Ankle Brachial Index in acute ischaemic stroke Patients from 85 German stroke units[J].J Neurol Neurosurg Psychiatry,2008,79(12):1339-1343.
  • 9Meng X,Wang Y,Zhao X,et al.Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese patients[J].Stroke,2011,42:3619-3620.
  • 10Weimar C,Diener HC,Alberts MJ,et al.The Essen stroke risk score Predicts recurrent cardiovascular events:a validation within the Reduction of Atherothrombosis for Continued Health(REACH)registry[J].Stroke,2009,40(2):350-354.

二级参考文献24

  • 1Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack[J]. Cerebrovasc Dis, 2003, 16 Suppl 1:14-19.
  • 2No authors listed. CAST:randomised placebo- controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) collaborative group[J]. Lancet, 1997, 349:1641-1649.
  • 3Liu M, Wu B, Wang WZ, et al. Stroke in China: Epidemiology, prevention, and management strategies[J]. Lancet Neurol, 2007, 6:456-464.
  • 4Touze E, Varenne O, Chatellier G, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke:A systematic review and meta-analysis[J]. Stroke, 2005, 36:2748-2755.
  • 5Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients[J]. Neurology, 2010, 74:588-593.
  • 6Dhamoon MS, Sciacca RR, Rundek T, et al. Recurrent stroke and cardiac risks after first ischemic stroke:The Northern Manhattan study[J]. Neurology, 2006, 66:641-646.
  • 7Hankey GJ, Jamrozik K, Broadhurst R J, et al. Long- term risk of first recurrent stroke in the Perth community stroke study[J]. Stroke, 1998, 29:2491- 2500.
  • 8Rothwell PM. Prognostic models[J]. Pract Neurol, 2008, 8:242-253.
  • 9Weimar C, Diener HC, Alberts MJ, et al. The Essen stroke risk score predicts recurrent cardiovascular events:A validation within the REduction of Atherothrombosis for Continued Health (REACH) registry[J]. Stroke, 2009, 40:350-354.
  • 10CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J]. Lancet, 1996,348:1329-1339.

共引文献297

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部